A review: effects of neurofeedback on patients with mild cognitive impairment (MCI), and Alzheimer's disease (AD)

被引：1
|
作者：
Tazaki, Miyako [1 ]
机构：
[1] Toho Univ, Fac Med, Dept Psychol, Tokyo, Japan
来源：
FRONTIERS IN HUMAN NEUROSCIENCE | 2024年 / 17卷
关键词：
neurofeedback; cognitive decline; mild cognitive impairment; Alzheimer's disease; dementia; DEMENTIA; RISK;
D O I：
10.3389/fnhum.2023.1331436
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Neurofeedback training (NFT) is a non-invasive method and has been shown to be effective for attention deficit/hyperactivity disorder (ADHD) and various psychiatric disorders. The aim of this paper is to evaluate the effectiveness of NFT for patients with Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD) or Vascular Diseases (VD), so that we searched research articles from four databases, using the keywords neurofeedback, elderly, MCI, AD, VD, and dementia. As a result, 13 articles were identified regarding the effectiveness of NFT in patients with MCI and AD. Although each study differed in study design, training protocol, electroencephalogram (EEG) electrode placement, and reward and inhibition frequency bands, all were shown to enhance memory, attention, and other cognitive abilities. Additional well-designed, randomized studies with sufficient power are needed to further confirm the effectiveness of NFT.
引用
收藏
页数：5
相关论文
共 50 条
  • [11] Quantitative electroencephalography (qEEG) as a prognostic marker of progression in mild cognitive impairment (MCI) and mild Alzheimer's disease (AD)
    Nielsen, M. Schjonning
    Simonsen, A. Hviid
    Hasselbalch, S. G.
    Hogh, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 603 - 603
  • [12] Can cognitive testing predict who will convert from mild cognitive impairment (MCI) to Alzheimer's disease (AD)?
    Belfor, N
    Kramer, JH
    Glenn, S
    Johnson, J
    Miller, BL
    CLINICAL NEUROPSYCHOLOGIST, 2005, 19 (3-4) : 541 - 541
  • [13] Neurotrophic substrate of mild cognitive impairment (MCI) in the elderly: Is MCI already Alzheimer's disease
    Mufson, Elliott J.
    Counts, Scott E.
    Ginsberg, Stephen D.
    BRAIN PATHOLOGY, 2006, 16 : S157 - S157
  • [14] Automatic classification of patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI) who will convert to AD using deep neural networks
    Agosta, F.
    Basaia, S.
    Wagner, L.
    Magnani, G.
    Filippi, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 279 - 279
  • [15] Automatic classification of patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI) who will convert to AD using deep neural networks
    Basaia, Silvia
    Agosta, Federica
    Wagner, Luca
    Magnani, Giuseppe
    Filippi, Massimo
    NEUROLOGY, 2018, 90
  • [16] The starving brain: Overfed meets undernourished in the pathology of mild cognitive impairment (MCI) and Alzheimer's disease (AD)
    Gibas, Kelly J.
    NEUROCHEMISTRY INTERNATIONAL, 2017, 110 : 57 - 68
  • [17] Assessment of progression in mild cognitive impairment (MCI) and Alzheimer's disease (AD) by a calibrated FDG PET score
    Herholz, Karl
    Westwood, Sarah
    Haense, Cathleen
    Dunn, Graham
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [18] Plasma levels of amyloid beta peptides are altered in mild cognitive impairment (MCI) but not in Alzheimer's disease (AD)
    Sobow, T
    Kloszewska, I
    NEUROBIOLOGY OF AGING, 2004, 25 : S356 - S356
  • [19] The Predicted Key Molecules, Functions, and Pathways That Bridge Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
    Tao Ye
    Han Yu
    Yu Lujiao
    Wang Qi
    Leng, Sean X.
    Zhang Haiyan
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [20] The cholinergic system in mild cognitive impairment (MCI) and Alzheimer disease
    DeKosky, S
    Ikonomovic, M
    Cochran, E
    Bennett, D
    Mufson, E
    NEUROBIOLOGY OF AGING, 2004, 25 : S6 - S7
12345